1 / 2

Proteinase K Market

The global proteinase K market size was valued at USD 66.52 million in 2020 and is projected to expand at a considerable CAGR during the forecast period, 2021 u2013 2028. The growth of the market is attributed to the wide use of enzymes rampant in DNA and RNA extraction and rising demand for in-vitro diagnostics.

Download Presentation

Proteinase K Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Proteinase K Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast The global proteinase K market size was valued at USD 66.52 million in 2020 and is projected to expand at a considerable CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the wide use of enzymes rampant in DNA and RNA extraction and rising demand for in-vitro diagnostics. The outbreak of the COVID-19 pandemic offers lucrative opportunities for the market growth as the pretreatment capacity of proteinase K is considered to be effective for the COVID-19 detection. The use of RT-qPCR to detect the COVID-19 virus has gained a lot of attention in the battle to stop the COVID-19 pandemic from spreading. Furthermore, for the diagnosis of COVID-19 infected individuals, PCR is considered to be the gold standard testing process. As the demand for diagnostic kits are in surge worldwide, the healthcare professionals and key players are working together to produce more testing devices. These professionals are also investigating the potential of updated protocols with direct-to-test enhancements, which can greatly improve the quality of test results besides assisting in the expansion of COVID-19 testing capability. Request Sample link :-https://growthmarketreports.com/request-sample/987 Market Trends, Drivers, Restraints, and Opportunities  Wide prevalence of chronic illness and infectious diseases across the globe is a major driver boosting the market. Increasing adoption of enzymes process for DNA and RNA extraction and rapid development of advance in-vitro diagnostics are expected to fuel the market development. 

  2. Rising spending on R&D activities from key players and implementation of favorable government bodies to develop innovative technology and devices for DNA and RNA testing are key factors driving the market growth. Factors such as time-consuming and expensive in respect to the COVID-19 PCR protocol's RNA extraction process associated with proteinase K treatment are key limitations that can restrict the scaling up of COVID-19 experiments. Lack of qualified staff handling various testing procedures and limited resource with constrained environments pose major challenges that can hamper the market growth.   Market Segment Insights: share Neurology Based on therapeutic areas, the global proteinase K market is divided into neurology, oncology, infectious diseases, diabetes, cardiology, nephrology, autoimmune diseases, and others. The neurology segment is anticipated to expand at a rapid pace during the forecast period owing to its wide applications. Using EDTA and proteinase K to treat Plasmodium DNA eliminates the need for DNA purification and isolation during PCR. segment is expected to represent a key Enquiry Link :- https://growthmarketreports.com/enquiry-before-buying/987 Competitive Landscape Some of the key players operating in the market are Merck KGaA; Codexis, Inc.; F. Hoffmann-La Roche Ltd.; Amano Enzyme Inc.; Advanced Enzymes Technologies Ltd.; Biocatalysts Ltd.; Amicogen; Dyadic International; BBI Solutions; Affymetrix; and American Laboratories. Several kits involving the use of proteinase K that can be applied for a wide range of applications are increasingly being produced by key players. For example, Leica Biosystems' Novocastra Enzyme Proteinase K (IHC) RE7160-K is used to enzymatically pre-treat paraffin-embedded or formalin-fixed tissue before incubation with an antibody during Immunohistochemical (IHC) analysis of tissue samples. About Growth Market Reports: GMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys. Contact: Growth Market Reports Phone: +1 909 414 1393 Email: sales@growthmarketreports.com Web: https://growthmarketreports.com Follow Us: LinkedIn | Twitter

More Related